Given the differences in the MedDRAs categorization rules, some potential PTs that were not included may exist, e.g., depression suicidal (belonging to HLGT level, depressed mood disorders and disturbances) and intentional overdose (belonging to HLGT level, overdoses, and underdoses NEC)
The first published tirzepatide injection site reaction case involved a patient who had tolerated dulaglutide for years without reactions, then developed a severe reaction covering the entire lower abdomen after switching to tirzepatide
Key research findings include: Average 24.2% body weight reduction in Phase 2 at the highest dose cohort over 48 weeks Significant reductions in waist circumference, triglycerides, and fasting glucose Weekly subcutaneous injection (half-life approximately 6 days) Most common adverse events: nausea, vomiting, diarrhea (typical of GLP-1 class) Requires cold chain storage (28C refrigerated)
A systematic review and doseresponse meta-analysis
After completing these steps, safely dispose of the used needle in a sharps container
However, the explosive consumer demand for semaglutide and tirzepatide weight-loss drugs has transformed compounding into a multibillion-dollar industry operating at a scale never originally envisioned by regulators